BiotechTube
CPL Sachse

CPL Sachse

Berlin, Germany· Est.
cpl-sachse.de
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

CPL Sachse is an established, privately-held CDMO with over 30 years of experience in pharmaceutical chemistry. Its core business is the contract development and cGMP-compliant manufacturing of organic APIs and intermediates, from milligrams to kilograms, serving both human and veterinary medicine markets. The company leverages its 'Smart API Chemistry' expertise to offer a full suite of services from early-stage synthesis to regulatory support, currently producing nine certified APIs for market supply. As a specialized service provider, its success is tied to the outsourcing trends and pipeline progression of its pharmaceutical clients.

Medical Devices

Technology Platform

Integrated 'Smart API Chemistry' CDMO platform offering synthesis development, cGMP API production (milligrams to kilograms), analytical method development/validation (specializing in GC for residual solvents), and regulatory support for organic APIs.

Opportunities

The growing trend of pharmaceutical outsourcing, especially among virtual and small biotech firms, drives demand for specialized CDMOs.
Increased focus on supply chain resilience in Europe benefits established, EU-GMP certified manufacturers like CPL Sachse.
The stable veterinary pharmaceutical market provides an additional revenue stream.

Risk Factors

Revenue depends on a limited number of commercial API manufacturing contracts, creating client concentration risk.
The highly competitive CDMO landscape pressures pricing and requires continuous operational excellence.
Any failure to maintain strict cGMP compliance could result in regulatory actions and reputational damage.

Competitive Landscape

CPL Sachse competes in a fragmented but intense global CDMO market, contending with large multinational players (e.g., Lonza, Catalent) and numerous European mid-sized specialists. Its differentiation lies in its integrated organic chemistry focus, SME agility, and deep regulatory experience within the German/EU framework. Competition is based on technical expertise, quality, reliability, cost, and capacity.

More companies in Small Molecule Drugs →More companies in Germany →